Göm menyn

Publications for Mårten Segelmark

Co-author map based on Web of Sciences articles 2007-

Publications mentioned in social media 599 times*

Journal Articles

Federica Maritati, Roberta Fenoglio, Evangeline Pillebout, Giacomo Emmi, Maria L. Urban, Rossana Rocco, Maria Nicastro, Monia Incerti, Matteo Goldoni, Giorgio Trivioli, Elena Silvestri, Aladdin J. Mohammad, David Jayne, Per Eriksson, Mårten Segelmark, Pavel Novikov, Helen Harris, Dario Roccatello and Augusto Vaglio
  Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schonlein)
  Arthritis & Rheumatology, 2018, 70(1), 109-114.
 Web of Science® Times Cited: 2

M. Mossberg, Mårten Segelmark, R. Kahn, M. Englund and A. J. Mohammad
  Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden
  Scandinavian Journal of Rheumatology, 2018, 47(4), 295-302.
 Web of Science® Times Cited: 1

Per Eriksson, Mårten Segelmark and Olof Hallböök
  Frequency, Diagnosis, Treatment, and Outcome of Gastrointestinal Disease in Granulomatosis with Polyangiitis and Microscopic Polyangiitis
  Journal of Rheumatology, 2018, 45(4), 529-537.

Ulrika Lindberg, Lisbeth Svensson, Thomas Hellmark, Mårten Segelmark and Oonagh Shannon
  Increased platelet activation occurs in cystic fibrosis patients and correlates to clinical status
  Thrombosis Research, 2018, 162, 32-37.

Giovanna Clavarino, Arnaud Gauthier, Thomas Hellmark, Pierre-Louis Carron, Diane Giovannini, Sophie Colliard, Marie-Agnes Dragon-Durey, Mårten Segelmark, Jean-Yves Cesbron and Chantal Dumestre-Perard
  Letter: Routinely used immunoassays do not detect circulating anti-GBM antibodies against native NC1 hexamer and EA epitope of the 3 chain of type IV collagen in EUROPEAN JOURNAL OF IMMUNOLOGY, vol 48, issue 6, pp 1082-1084
  European Journal of Immunology, 2018, 48(6), 1082-1084.

Björn Ingelsson, Daniel Söderberg, Tobias Strid, Anita Söderberg, Ann-Charlotte Bergh, Vesa-Matti Loitto, Kourosh Lotfi, Mårten Segelmark, Giannis Spyrou and Anders Rosén
  Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C.
  Proceedings of the National Academy of Sciences of the United States of America, 2018, 115(3), E478-E487.
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Daniel Söderberg and Mårten Segelmark
  Neutrophil extracellular traps in vasculitis, friend or foe?
  Current Opinion in Rheumatology, 2018, 30(1), 16-23.

Maria Mossberg, Anne-lie Stahl, Robin Kahn, Ann-Charlotte Kristoffersson, Ramesh Tati, Caroline Heijl, Mårten Segelmark, L. M. Fredrik Leeb-Lundberg and Diana Karpman
  Cl-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles
  Journal of the American Society of Nephrology, 2017, 28(8), 2472-2481.
 Web of Science® Times Cited: 3

Robin Kahn, Maria Mossberg, Anne-lie Stahl, Karl Johansson, Ingrid Lopatko Lindman, Caroline Heijl, Mårten Segelmark, Matthias Morgelin, L. M. Fredrik Leeb-Lundberg and Diana Karpman
  Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis
  KIDNEY INTERNATIONAL, 2017, 91(1), 96-105.
 Web of Science® Times Cited: 8

Stephen P. McAdoo, Anisha Tanna, Zdenka Hruskova, Lisa Holm, Maria Weiner, Nishkantha Arulkumaran, Amy Kang, Veronika Satrapova, Jeremy Levy, Sophie Ohlsson, Vladimir Tesar, Mårten Segelmark and Charles D. Pusey
  Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients
  Kidney International, 2017, 92(3), 693-702.
 Web of Science® Times Cited: 3

Alexandre Karras, Christian Pagnoux, Marion Haubitz, Kirsten de Groot, Xavier Puechal, Jan Willem Cohen Tervaert, Mårten Segelmark, Loic Guillevin and David Jayne
  Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis
  Annals of the Rheumatic Diseases, 2017, 76(10), 1662-1668.
 Web of Science® Times Cited: 10

David R. W. Jayne, Annette N. Bruchfeld, Lorraine Harper, Matthias Schaier, Michael C. Venning, Patrick Hamilton, Volker Burst, Franziska Grundmann, Michel Jadoul, Istvan Szombati, Vladimir Tesar, Mårten Segelmark, Antonia Potarca, Thomas J. Schall and Pirow Bekker
  Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
  Journal of the American Society of Nephrology, 2017, 28(9), 2756-2767.
 Web of Science® Times Cited: 29

Aladdin J. Mohammad, Mårten Segelmark, Rona Smith, Martin Englund, Jan-Ake Nilsson, Kerstin Westman, Peter A. Merkel and David R. W. Jayne
  Severe Infection in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
  Journal of Rheumatology, 2017, 44(10), 1468-1475.
 Web of Science® Times Cited: 2

Max Yates, Richard Watts, Ingeborg Bajema, Maria Cid, Bruno Crestani, Thomas Hauser, Bernhard Hellmich, Julia Holle, Martin Laudien, Mark A Little, Raashid Ahmed Luqmani, Alfred Mahr, Peter Merkel, John Mills, Janice Mooney, Mårten Segelmark, Vladimir Tesar, Kerstin W A Westman, Augusto Vaglio, Nilüfer Yalçindag, David R Jayne and Chetan Mukhtyar
  Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts
  RMD open, 2017, 3(1), .
   Fulltext  PDF  

Martin Englund, Peter A. Merkel, Gunnar Tomasson, Mårten Segelmark and Aladdin J. Mohammad
  Comorbidities in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis versus the General Population
  Journal of Rheumatology, 2016, 43(8), 1553-1558.
 Web of Science® Times Cited: 7

M. Yates, R. A. Watts, I. M. Bajema, M. C. Cid, B. Crestani, T. Hauser, B. Hellmich, J. U. Holle, M. Laudien, M. A. Little, R. A. Luqmani, A. Mahr, P. A. Merkel, J. Mills, J. Mooney, Mårten Segelmark, V. Tesar, K. Westman, A. Vaglio, N. Yalcindag, D. R. Jayne and C. Mukhtyar
  EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
  Annals of the Rheumatic Diseases, 2016, 75(9), 1583-1594.
   Fulltext  PDF  
 Web of Science® Times Cited: 100

Helena Rydell, Naomi Clyne and Mårten Segelmark
  Home- or Institutional Hemodialysis? - a Matched Pair-Cohort Study Comparing Survival and Some Modifiable Factors Related to Survival
  Kidney and Blood Pressure Research, 2016, 41(4), 392-401.
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Charlotta Sandin, Per Eriksson, Mårten Segelmark, Thomas Skogh and Alf Kastbom
  IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA associated vasculitis.
  Clinical and Experimental Immunology, 2016, 184(2), 208-215.
 Web of Science® Times Cited: 3

Maria Pippias, Vianda S. Stel, Nuria Areste-Fosalba, Cecile Couchoud, Gema Fernandez-Fresnedo, Patrik Finne, James G. Heaf, Andries Hoitsma, Johan De Meester, Runolfur Palsson, Pietro Ravani, Mårten Segelmark, Jamie P. Traynor, Anna V. Reisaeter, Fergus J. Caskey and Kitty J. Jager
  Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry
  Transplantation, 2016, 100(9), 1955-1962.
 Web of Science® Times Cited: 8

Daniel Söderberg and Mårten Segelmark
  Neutrophil Extracellular Traps in ANCA-Associated Vasculitis
  Frontiers in Immunology, 2016, 7(UNSP 256), .
   Fulltext  PDF  
 Web of Science® Times Cited: 17

Duvuru Geetha, Zdenka Hruskova, Mårten Segelmark, Jonathan Hogan, Matthew D Morgan, Teresa Cavero, Per Eriksson, Philip Seo, Rebecca L Manno, Jessica Dale, Lorraine Harper, Vladimir Tesar and David Rw Jayne
  Rituximab for treatment of severe renal disease in ANCA associated vasculitis
  JN. Journal of Nephrology (Milano. 1992), 2016, 29(2), 195-201.
 Web of Science® Times Cited: 3

Maria Weiner and Mårten Segelmark
  The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA)
  Autoimmunity Reviews, 2016, 15(10), 978-982.
   Fulltext  PDF  
 Web of Science® Times Cited: 15

Moniek W. M. van de Luijtgaarden, Kitty J. Jager, Mårten Segelmark, Julio Pascual, Frederic Collart, Aline C. Hemke, Cesar Remon, Wendy Metcalfe, Alfonso Miguel, Reinhard Kramar, Knut Aasarod, Ameen Abu Hanna, Raymond T. Krediet, Staffan Schon, Pietro Ravani, Fergus J. Caskey, Cecile Couchoud, Runolfur Palsson, Christoph Wanner, Patrik Finne and Marlies Noordzij
  Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period
  Nephrology, Dialysis and Transplantation, 2016, 31(1), 120-128.
 Web of Science® Times Cited: 33

Ulrika Lindberg, Malin Carlsson, Thomas Hellmark and Mårten Segelmark
  BPI-ANCA Provides Additional Clinical Information to Anti-Pseudomonas Serology: Results from a Cohort of 117 Swedish Cystic Fibrosis Patients
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Camilla Skoglund, A L Carlsen, Maria Weiner, Tino Kurz, Thomas Hellmark, Per Eriksson, N H H Heegaard and Mårten Segelmark
  Circulating microRNA expression pattern separates patients with anti-neutrophil cytoplasmic antibody associated vasculitis from healthy controls.
  Clinical and Experimental Rheumatology, 2015, 33(2 Suppl 89), S64-S71.
 Web of Science® Times Cited: 5

Dimitrios Venetsanos, Joakim Alfredsson, Mårten Segelmark, Eva Swahn and Sofia Lawesson
  Glomerular filtration rate (GFR) during and after STEMI: a single-centre, methodological study comparing estimated and measured GFR
  BMJ Open, 2015, 5(9), 1-8.
   Fulltext  PDF  
 Web of Science® Times Cited: 3

Aladdin J Mohammad, Maria Weiner, Christopher Sjöwall, Martin E Johansson, Anders A Bengtsson, Christina Ståhl-Hallengren, Ola Nived, Per Eriksson, Gunnar Sturfelt and Mårten Segelmark
  Incidence and disease severity of anti-neutrophil cytoplasmic antibody-associated nephritis are higher than in lupus nephritis in Sweden.
  Nephrology, Dialysis and Transplantation, 2015, 30, i23-i30.
 Web of Science® Times Cited: 4

Daniel Söderberg, Tino Kurz, Atbin Motamedi, Thomas Hellmark, Per Eriksson and Mårten Segelmark
  Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission
  Rheumatology, 2015, 54(11), 2085-2094.
   Fulltext  PDF  
 Web of Science® Times Cited: 24

Mårten Segelmark, Diana Karpman, Ingela Fehrman-Ekholm, Peter Bárány, Zivile Békássy, Per Brandström, Annette Bruchfeld, Gianni Celsi, Milan Chromek, Naomi Clyne, Bengt Fellström, Sverker Hansson, Börje Haraldsson, Tryggve Nevéus, Bengt Rippe, Lisa Sartz, Bernd Stegmayr, Peter Stenvinkel and Kerstin Westman
  NT-rådet bör omedelbart återkalla sitt beslut om eculizumab
  Läkartidningen, 2015, 112, .

Mårten Segelmark, Diana Karpman, Ingela Fehrman-Ekholm, Peter Bárány, Zivile Békássy, Per Brandström, Annette Bruchfeld, Gianni Celsi, Milan Chromek, Naomi Clyne, Bengt Fellström, Sverker Hansson, Börje Haraldsson, Tryggve Nevéus, Bengt Rippe, Lisa Sartz, Bernd Stegmayr, Peter Stenvinkel, Gunnar Tufveson and Kerstin Westman
  NT-rådets ställningstagande till eculizumab är oacceptabelt
  Läkartidningen, 2015, 112, .

Maria Weiner, Su Mein Goh, Aladdin J Mohammad, Zdenka Hruskova, Anisha Tanna, Annette Bruchfeld, Daina Selga, Zdenka Chocova, Kerstin Westman, Per Eriksson, Charles D Pusey, Vladimir Tesar, Alan D Salama and Mårten Segelmark
  Outcome and Treatment of Elderly Patients with ANCA-Associated Vasculitis
  Clinical journal of the American Society of Nephrology : CJASN, 2015, 10(7), 1128-1135.
   Fulltext  PDF  
 Web of Science® Times Cited: 14

Rachel B. Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert, Thomas Hauser, Raashid Luqmani, Matthew D. Morgan, Chen Au Peh, Caroline O. Savage, Mårten Segelmark, Vladimir Tesar, Pieter van Paassen, Michael Walsh, Kerstin Westman and David R. W. Jayne
  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
  Annals of the Rheumatic Diseases, 2015, 74(6), 1178-1182.
 Web of Science® Times Cited: 51

Shivani Shah, Zdenka Hruskova, Mårten Segelmark, Matthew D Morgan, Jonathan Hogan, Steven K Lee, Jessica Dale, Lorraine Harper, Vladimir Tesar, David R W Jayne and Duvuru Geetha
  Treatment of Severe Renal Disease in ANCA Positive and Negative Small Vessel Vasculitis with Rituximab.
  American Journal of Nephrology, 2015, 41(4-5), 296-301.
 Web of Science® Times Cited: 11

Tino Kurz, Maria Weiner, Camilla Skoglund, Sandeep Basnet, Per Eriksson and Mårten Segelmark
  A myelopoiesis gene signature during remission in ANCA associated vasculitis does not predict relapses but seems to reflect ongoing prednisolone therapy
  Clinical and Experimental Immunology, 2014, 175(2), 215-226.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Aladdin J. Mohammad and Mårten Segelmark
  A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis
  Journal of Rheumatology, 2014, 41(7), 1366-1373.
 Web of Science® Times Cited: 19

Sophie Ohlsson, Hans Herlitz, Sigrid Lundberg, Daina Selga, Johan Molne, Jorgen Wieslander and Mårten Segelmark
  Circulating Anti-Glomerular Basement Membrane Antibodies With Predominance of Subclass IgG4 and False-Negative Immunoassay Test Results in Anti-Glomerular Basement Membrane Disease
  American Journal of Kidney Diseases, 2014, 63(2), 289-293.
   Fulltext  PDF  
 Web of Science® Times Cited: 30

Thomas Hellmark and Mårten Segelmark
  Diagnosis and classification of Goodpastures disease (anti-GBM)
  Journal of Autoimmunity, 2014, 48-49, 108-112.
   Fulltext  PDF  
 Web of Science® Times Cited: 22

Sophie Ohlsson and Mårten Segelmark
  In Reply to IgG4-Restricted Anti-Glomerular Basement Membrane Autoantibodies Targeting Quaternary Epitopes of Native alpha 345(IV) Collagen
  American Journal of Kidney Diseases, 2014, 64(1), 157-157.
   Fulltext  PDF  

Susanne M. Ohlsson, Sophie Ohlsson, Daniel Söderberg, Lena Gunnarsson, Åsa Pettersson, Mårten Segelmark and Thomas Hellmark
  Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies
  Clinical and Experimental Immunology, 2014, 176(3), 363-372.
   Fulltext  PDF  
 Web of Science® Times Cited: 15

Peter Stenvinkel, Gerd Faxén Irving, Sigrid Wegener, Sintra Eyre, Bengt Rippe, Mårten Segelmark, Peter Barany and Ola Samuelsson
  [Phosphate additives in food a potential public health risk. High phosphate levels can lead to cardiovascular disease].
  Läkartidningen, 2014, 111(27-28), 1176-1179.

A. Mohammad and Mårten Segelmark
  Primary systemic vasculitis with severe alpha(1)-antitrypsin deficiency revisited
  Scandinavian Journal of Rheumatology, 2014, 43(3), 242-245.
 Web of Science® Times Cited: 5

Mårten Segelmark, Håkan Hedman, Bengt Rippe, Peter Stenvinkel and Börje Haraldsson
  Skolhälsovården missar barn med njursjukdom
  Svenska Dagbladet, 2014, , .

Xiang Peng, Sofia Ramström, Tino Kurz, Magnus Grenegård and Mårten Segelmark
  The neutrophil serine protease PR3 induces shape change of platelets via the Rho/Rho kinase and Ca2+ signaling pathways
  Thrombosis Research, 2014, 134(2), 418-425.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Ulf Persson, Birgitta Gullstrand, Asa Pettersson, Gunnar Sturfelt, Lennart Truedsson and Mårten Segelmark
  A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fc gamma-RIIa Genes
  Kidney and Blood Pressure Research, 2013, 37(6), 641-648.
   Fulltext  PDF  
 Web of Science® Times Cited: 7

Anting Liu Carlsen, Aaron J. Schetter, Christoffer T. Nielsen, Christian Lood, Steen Knudsen, Anne Voss, Curtis C Harris, Thomas Hellmark, Mårten Segelmark, Soren Jacobsen, Anders A. Bengtsson and Niels H H. Heegaard
  Circulating MicroRNA Expression Profiles Associated With Systemic Lupus Erythematosus
  Arthritis and Rheumatism, 2013, 65(5), 1324-1334.
 Web of Science® Times Cited: 111

Helena Rydell, Lena Krutzen, Ole Simonsen, Naomi Clyne and Marten Segelmark
  Excellent long time survival for Swedish patients starting home-hemodialysis with and without subsequent renal transplantations
  Hemodialysis International, 2013, 17(4), 523-531.
 Web of Science® Times Cited: 3

Aladdin Mohammad, Thomas Mandl, Gunnar Sturfelt and Mårten Segelmark
  Incidence, prevalence and clinical characteristics of Behcets disease in southern Sweden
  Rheumatology, 2013, 52(2), 304-310.
 Web of Science® Times Cited: 33

Mårten Segelmark
  Renal transplantation in ANCA-associated vasculitis
  La Médicale, 2013, 42(4), 568-571.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Gunilla Grundstrom, Anders Christensson, Maria Alquist, Lars-Goran Nilsson and Marten Segelmark
  Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility
  BMC Nephrology, 2013, 14(216), .
   Fulltext  PDF  
 Web of Science® Times Cited: 13

Mårten Segelmark, Per Dahlberg and Jörgen Wieslander
  Anti-GBM disease with a mild relapsing course and low levels ofanti-GBM autoantibodies
  Clinical Kidney Journal, 2012, 5(6), 549-551.

Ulrika Lindberg, Malin Carlsson, Claes-Göran Löfdahl and Mårten Segelmark
  BPI-ANCA and long-term prognosis among 46 adult CF patients: a prospective 10-year follow-up study
  Clinical and Development Immunology, 2012, (370107), .
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Mohamed Abdgawad, Asa Pettersson, Lena Gunnarsson, Anders A Bengtsson, Pierre Geborek, Lars Nilsson, Mårten Segelmark and Thomas Hellmark
  Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis
  PLoS ONE, 2012, 7(3), .
   Fulltext  PDF  
 Web of Science® Times Cited: 41

Michael C Carlsson, Crina I A Balog, Ola Kilsgard, Thomas Hellmark, Omran Bakoush, Mårten Segelmark, Marten Ferno, Hakan Olsson, Johan Malmstrom, Manfred Wuhrer and Hakon Leffler
  Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease
  Biochimica et Biophysica Acta - General Subjects, 2012, 1820(9), 1366-1372.
   Fulltext  PDF  
 Web of Science® Times Cited: 16

K Aanaes, N Rasmussen, T Pressler, Mårten Segelmark, H K Johansen, U Lindberg, N Hoiby, M Carlsson, J Wieslander and C Buchwald
  Extensive Endoscopic Image-Guided Sinus Surgery Decreases BPI-ANCA in Patients with Cystic Fibrosis
  Scandinavian Journal of Immunology, 2012, 76(6), 573-579.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Michael C Carlsson, Omran Bakoush, Lotta Tengroth, Ola Kilsgard, Johan Malmstrom, Thomas Hellmark, Mårten Segelmark and Hakon Leffler
  Galectin-8 in IgA Nephritis: Decreased Binding of IgA by Galectin-8 Affinity Chromatography and Associated Increased Binding in Non-IgA Serum Glycoproteins
  Journal of Clinical Immunology, 2012, 32(2), 246-255.
   Fulltext  PDF  
 Web of Science® Times Cited: 4

Paul A Lyons, Tim F Rayner, Sapna Trivedi, Julia U Holle, Richard A Watts, David R W Jayne, Bo Baslund, Paul Brenchley, Annette Bruchfeld, Afzal N Chaudhry, Jan Willem Cohen Tervaert, Panos Deloukas, Conleth Feighery, Wolfgang L Gross, Loic Guillevin, Iva Gunnarsson, Lorraine Harper, Zdenka Hruskova, Mark A Little, Davide Martorana, Thomas Neumann, Sophie Ohlsson, Sandosh Padmanabhan, Charles D Pusey, Alan D Salama, Jan-Stephan F Sanders, Caroline O Savage, Mårten Segelmark, Coen A Stegeman, Vladimir Tesar, Augusto Vaglio, Stefan Wieczorek, Benjamin Wilde, Jochen Zwerina, Andrew J Rees, David G Clayton and Kenneth G C Smith
  Genetically Distinct Subsets within ANCA-Associated Vasculitis
  New England Journal of Medicine, 2012, 367(3), 214-223.
 Web of Science® Times Cited: 352

Mårten Segelmark, Ole Simonsen, Susanne Ljungman, Britta Hylander, Olof Heimbürger, Ann-Chatrine Johansson, Gudrun Malmsten and Berndt Stegmayr
  Ojämn tillgång till vård i landet: Assisterad peritonealdialys erbjuds inte till alla som behöver det
  Läkartidningen, 2012, 109(9-10), 452-453.

S M Ohlsson, A Pettersson, S Ohlsson, D Selga, A A Bengtsson, Mårten Segelmark and T Hellmark
  Phagocytosis of apoptotic cells by macrophages in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis
  Clinical and Experimental Immunology, 2012, 170(1), 47-56.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Mårten Segelmark and Fredrik Palm
  Vävnadshypoxi viktig faktor för uppkomst och progression av kronisk njursvikt
  Vaskulär medicin, 2012, 28(3), 134-138.

Aladdin Mohammad and Mårten Segelmark
  Association of cigarette smoking with organ damage in primary systemic vasculities
  Scandinavian Journal of Rheumatology, 2011, 40(1), 51-56.
 Web of Science® Times Cited: 3

Mårten Segelmark
  Genes that link nephritis to autoantibodies and innate immunity.
  New England Journal of Medicine, 2011, 364(7), 679-680.
 Web of Science® Times Cited: 5

Malin Carlsson, Swati Shukla, Ann Cathrine Petersson, Mårten Segelmark and Thomas Hellmark
  Pseudomonas aeruginosa in cystic fibrosis: Pyocyanin negative strains are associated with BPI-ANCA and progressive lung disease
  Journal of Cystic Fibrosis, 2011, 10(4), 265-271.
 Web of Science® Times Cited: 13

Aladdin Mohammad and Mårten Segelmark
  ANCA associerade systemiska vaskuliter och polyarteritis nodosa – epidemiologi
  Best practice Reumatologi, 2010, (2), 5-8.

Mårten Segelmark and Thomas Hellmark
  Autoimmune kidneydisease
  Autoimmunity Reviews, 2010, 9(5), A366-A371.
 Web of Science® Times Cited: 41

M. Abdgawad, L. Gunnarsson, A. A. Bengtsson, P. Geborek, L. Nilsson, Mårten Segelmark and T. Hellmark
  Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression
  Clinical and Experimental Immunology, 2010, 161(1), 89-97.
 Web of Science® Times Cited: 23

D. Selga, Mårten Segelmark, L. Gunnarsson and T. Hellmark
  Epitope shift of proteinase-3 anti-neutrophil cytoplasmic antibodies in patients with small vessel vasculitis
  Clinical and Experimental Immunology, 2010, 160(3), 318-324.
 Web of Science® Times Cited: 8

Neil Basu, Richard Watts, Ingeborg Bajema, Bo Baslund, Thorsten Bley, Maarten Boers, Paul Brogan, Len Calabrese, Maria C Cid, Jan Willem Cohen-Tervaert, Luis Felipe Flores-Suarez, Shouichi Fujimoto, Kirsten de Groot, Loic Guillevin, Gulen Hatemi, Thomas Hauser, David Jayne, Charles Jennette, Cees G M Kallenberg, Shigeto Kobayashi, Mark A Little, Alfred Mahr, John McLaren, Peter A Merkel, Seza Ozen, Xavier Puechal, Niels Rasmussen, Alan Salama, Carlo Salvarani, Caroline Savage, David G I Scott, Mårten Segelmark, Ulrich Specks, Cord Sunderköetter, Kazuo Suzuki, Vladimir Tesar, Allan Wiik, Hasan Yazici and Raashid Luqmani
  EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis
  Annals of the Rheumatic Diseases, 2010, 69(10), 1744-1750.
 Web of Science® Times Cited: 85

Zhao Cui, Ming-hui Zhao, Mårten Segelmark and Thomas Hellmark
  Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals
  Kidney International, 2010, 78(6), 590-597.
 Web of Science® Times Cited: 61

Rachel B. Jones, Jan Willem Cohen Tervaer, Thomas Hauser, Raashid Luqmani, Matthew D. Morgan, Chen Au Peh, Caroline O. Savage, Mårten Segelmark, Vladimir Tesar, Pieter van Paassen, Dorothy Wals, Michael Walsh, Kerstin Westman and David R.W. Jayne
  Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
  New England Journal of Medicine, 2010, 363(3), 211-220.
 Web of Science® Times Cited: 620

Rui Yang, Marielle A. Otten, Thomas Hellmark, Mattias Collin, Lars Björck, Ming-Hui Zhao, Mohamed R. Daha and Mårten Segelmark
  Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes
  Nephrology, Dialysis and Transplantation, 2010, 25(8), 2479-2486.
 Web of Science® Times Cited: 36

Mårten Segelmark
  Incidence and Survival rates in Wegener´s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and Polyarteritis nodosa
  Rheumatology (Oxford), 2009, Dec(48(12)), 1560-5.
 Web of Science® Times Cited: 85

Rui Yang, Thomas Hellmark, Juan Zhao, Zhao Cui, Mårten Segelmark, Ming-hui Zhao and Hai-yan Wang
  Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease
  Nephrology, Dialysis and Transplantation, 2009, 24(6), 1838-1844.
 Web of Science® Times Cited: 25

Sophie Ohlsson, Omran Bakoush, Jan Tencer, Ole Torffvit and Mårten Segelmark
  Monocyte Chemoattractant Protein 1 is a Prognostic Marker in ANCA-Associated Small Vessel Vasculitis
  Mediators of Inflammation, 2009, 2009((2009)), Art.-ID 584916.
   Fulltext  PDF  
 Web of Science® Times Cited: 19

A. J. Mohammad, O. Bakoush, G. Sturfelt and Mårten Segelmark
  The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI)
  Scandinavian Journal of Rheumatology, 2009, 38(4), 268-265.
 Web of Science® Times Cited: 10

Fredrik Kahn, Anna Fagerström, Mårten Segelmark and Omran Bakoush
  Irreversible Kidney Damage due to Multicentric Castlemans Disease
  Libyan Journal of Medicine, 2008, 3(2), 101-103.
 Web of Science® Times Cited: 1

Mårten Segelmark
  Antigen and epitope specificity of anti-glomerular basement membrane antiodies in patients with Goodpasture´s disease with or without anti-neutrophil cytoplasmic antibodies.
  J Am Soc Nephrol, 2007, Apr(18(4)), 1338-43.
 Web of Science® Times Cited: 48

Mårten Segelmark
  Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis
  J Cyst Fibros, 2007, May(6(3)), 228-33.
 Web of Science® Times Cited: 25

Mårten Segelmark
  Development and validation of a consensus methodology for the classification of the Primary Systemic Vasculitides for epidemiological studies
  Ann Rheum Dis, 2007, Feb(66(2)), 222-7.
 Web of Science® Times Cited: 423

Mårten Segelmark
  Natural anti-GBM antibodies from normal human sera recognize alpha3 (IV) NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.
  Clinical Immunology, 2007, Aug(124(2)), 207-12.
 Web of Science® Times Cited: 23

Mårten Segelmark
  Prevalence of Wegener´s granulomatosis, Microscopic polyangiitis, Polyarteritis nodosa, and Churg-Strauss syndrome within a defined population in southern Sweden
  Rheumatology (Oxford), 2007, Aug(46(8)), 1329-37.
 Web of Science® Times Cited: 94

Mårten Segelmark
  Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils.
  J Leukoc Biol., 2007, Feb(81(2)), 458-64.
 Web of Science® Times Cited: 71

Mårten Segelmark
  På väg mot en evidensbaserad terapi för primärsystemisk vaskulit
  Läkartidningen, 2007, 12(104), 954-957.

Mårten Segelmark
  The challenge ofmanaging patients with polyarteritis nodosa
  Current Opinion in Rheumatology, 2007, Jan(19(1)), 33-8.
 Web of Science® Times Cited: 17

Mårten Segelmark
  Thirty-Five Years of Hemedialysis: Two Case Reports as A Tribute to Nils Alwall
  Am J Kidney Dis, 2007, Mar(49(3)), 471-6.
 Web of Science® Times Cited: 4

Mårten Segelmark
  Increased Membrane Expression and Plasma Concentrations of Proteianse 3 (PR3) in Vasculitis is not a Consequence of the -564 A/G Gene Promotor Polymorphism
  Clinical and Experimental Immunology, 2006, Jul(145(1)), 63-70.
 Web of Science® Times Cited: 14

Mårten Segelmark
  Polyarteritis nodosa when applying the Chapel Hill nomenclature - A descriptive study on ten patients
  Rheumatology, 2006, Oct(45(10)), 1276-81.
 Web of Science® Times Cited: 20

Mårten Segelmark
  Urine IgM excretion predicts outcome in ANCA-associated renal vasculitis.
  Nephrology, Dialysis and Transplantation, 2006, May(21(5)), 1263-9.
 Web of Science® Times Cited: 29

Mårten Segelmark
  Alport syndrome caused by inversion of a 21 Mb fragment of the long arm of the X-chromosome comprising exon 9 through 51 of the COL4A5 gene
  Human Genetics, 2005, (118), 23-28.
 Web of Science® Times Cited: 4

Mårten Segelmark
  Alports syndrome in Southern Sweden
  Clinical Nephrology, 2005, Aug(64(2)), 85-90.
 Web of Science® Times Cited: 7

Mårten Segelmark
  Deficiency of the mannan-binding ledtin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship
  Clinical and Experimental Immunology, 2005, Feb(139(2)), 306-13.
 Web of Science® Times Cited: 48

Mårten Segelmark
  Increased monocyte transcription of the proteianse 3 gene
  Clinical and Experimental Immunology, 2005, Jul(141(1)), 174-82.
 Web of Science® Times Cited: 24

Mårten Segelmark
  Rapid resolution of erythropoietin-induced pure red cell aplasia after a course of immunoadsorption therapy using Protein A columns
  American Journal of Kidney Diseases, 2005, Jun(45(6)), e97-9.
 Web of Science® Times Cited: 4

Mårten Segelmark
  Circulating cytokine profile in ANCA-associated vasculitis-prediction of outcome?
  Mediators of Inflammation, 2004, Aug(13(4)), 275-83.

Mårten Segelmark
  Epitope mapping of anti-PR3 antibodies usin chimeric human PR3/mouse PR3 recombinant proteins.
  Clinical and Experimental Immunology, 2004, Jan(135(1)), 164-72.

Mårten Segelmark
  Patients with Goodpasture´s disease are born with two normal alleles coding for the NC1 domain of the Typ IV collagen a3 chain
  Nephrology, Dialysis and Transplantation, 2004, Aug(19(8)), 2030-5.

Mårten Segelmark
  Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission
  Clinical and Experimental Immunology, 2003, Mar(131(3)), 528-35.

Mårten Segelmark
  Increased expression of the secretory leukocyte proteinbase inhibitor in Wegener´s granulomatosis
  Clinical and Experimental Immunology, 2003, Jan(131(1)), 190-6.

Mårten Segelmark
  Monitoring PR3-ANCA for the Detection of Relapses in Small Vessel Vasculitis
  Clinical and diagnostic laboratory immunology, 2003, Sep(10(5)), 769-74.

Mårten Segelmark
  Pseudomonas induced lung damage in systic fibrosis correlate to BPI-autoantibodies.
  Clinical and Experimental Rheumatology, 2003, (21;6;32), S095-S100.

Mårten Segelmark
  The prognostic significance in Goodpasture´s disease of specificity, titer and affinity of anti-glomerular basement membrane antibodies.
  Nephron. Clinical practice, 2003, (94), c59-c68.

Mårten Segelmark
  Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperozidase with generation of intracellular oxidants
  The American Journal of Pathology, 2001, Feb(158(2)), 581-92.

Mårten Segelmark
  Novel distribution of the secretory leucocyte proteinase inhibitor in kidney
  Mediators of Inflammation, 2001, Dec(10(6)), 347-50.

Mårten Segelmark
  ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells.
  Kidney International, 2000, (57), 1981-1990.

Mårten Segelmark
  Expression of p300-truncated fragments results in the modulation of apoptosis in rat mesangial cells
  Kidney International, 2000, (57), 1873-1881.

Mårten Segelmark
  How and why should wedetect ANCA?
  Clinical and Experimental Rheumatology, 2000, Sep-Oct(18(5)), 629-35.

Mårten Segelmark
  Complement C3 and C4 genotypes in systemic vasculits
  Clinical and Experimental Immunology, 1999, (116(2)), 379-82.

Mårten Segelmark
  Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture´s syndrome.
  Kidney International, 1999, (55(3)), 936-44.

Mårten Segelmark
  Relapse of systematic vasculits after renal transplantation
  Kidney International, 1999, (56), 1544-1550.

Mårten Segelmark
  Clinical evaluation of a capture ELISA for detection of Proteinase 3 antineutrophil cytoplasmtic antibodies (PR3-ANCA)
  Kidney International, 1998, (53), 1230-1236.

Mårten Segelmark
  Anti-GBM antibodies inGoodpasture Syndrome: Anatomy of an epitope
  Nephrology, Dialysis and Transplantation, 1997, (12), 646-648.

Mårten Segelmark
  Autoantibodies againstcomponents of renal basement membranes.
  Neckars seminars in nephrology, 1997, , .

Mårten Segelmark
  Binding and inhibition of myeloperoxidase (MPO) - A major function of ceruloplasmin?
  Clin Exp Immunol, 1997, (108), 167-174.

Mårten Segelmark
  Preeclampsia is associated with a reduced response to activated protein C
  American Journal of Obstetrics & Gynecology, 1997, (176(2)), 457-460.

Mårten Segelmark
  Auto-anticorps dirigéscontre les composants des membranes basales rénales
  Flammarion Médecine-Sciences - Actulaités Néphrologiques, 1996, , 303-314.

Mårten Segelmark
  Systemic necrotizing vasculitides in severe alpha -antitrypsin deficiency.
  Q.J. Med, 1996, (89), 599-611.

Mårten Segelmark
  Screening for ANCA: Is indirect immunofluorescence the method of choice
  Clinical and Experimental Immunology, 1995, , 486-492.

Mårten Segelmark
  The PiZ gene of alpha-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis
  Kidney International, 1995, (48), 844-850.

Mårten Segelmark
  Some patients with anti-MPO have a c-ANCA pattern
  , 1994, (96), 458-465.

Mårten Segelmark
  Strong link between the alpha-antitrypsin PiZ allele and Wegener´s granulomatosis
  Journal of Internal MEdicine, 1994, (236), 543-548.

Mårten Segelmark
  ANCA and IgG subclasses. In: Gross WL, ed. ANCA Associated Vasculitides
  Advances in Experimental Medicine and Biology, 1993, (336), 71-75.

Mårten Segelmark
  IgG Subclasses of anti-neutrophil cytoplasm autoantibodies (ANCA)
  Nephrology, Dialysis, Transplantation, 1993, (8), 696-702.

Mårten Segelmark
  Antigen restriction and IgG subclasses among anti-GBM autoantibodies.
  Nephrology Dial Transplant, 1990, (5), 991-996.


Mårten Segelmark
  Glomerulonefriter. In: Njursjukdomar
    Liber, 2008.

Mårten Segelmark
  Glomerulonefriter vid systemsjukdomar ochinfektioner.
    Liber, 2008.

Mårten Segelmark
  Goodpasture’s diseaseIn: Schoenfeld Y, Cervera R, Gershwin ME, eds. Diagnostic Criteria for the Autoimmune Diseases
    Humana Press Barcelona, 2008.

Mårten Segelmark
  Glomerular basement membraneantibodies.
    Elsevier Science B.V., 1996.

Chapters in Books

Mårten Segelmark
  Njursjukdom vid vaskulit
  Njursjukdom: teori och klinik, Studentlitteratur AB, 2015, 113-123.

Mårten Segelmark, Sigrid Lundberg and Johan Mölne
  Njursjukdomar, Liber, 2014, 85-99.

Mårten Segelmark and Johan Mölne
  Glomerulonefrit vid systemsjukdomar och infektioner
  Njursjukdomar, Liber, 2014, 100-111.

Conference Articles

Inga Sölve, Johan Mölne, Thomas Nilsson, Fredrik Uhlin and Mårten Segelmark
  Rapid clearance of antiGBM antibodies using IdeS, Three cases
  Nordic Society of Nephrology, Malmö 20-23 Sep. 2017, 2017.

K Solem, Mårten Segelmark and B Olde

K Solem, Mårten Segelmark and B Olde

Mårten Segelmark
  Natural ANCA Antibodies in CLINICAL AND EXPERIMENTAL IMMUNOLOGY, vol 164, issue , pp 48-49

Aladdin Mohammad and Mårten Segelmark
  Prevalence of ANCA Associated Vasculitis and Polyarteritis Nodosa in Southern Sweden-Revisited 2010 in ARTHRITIS AND RHEUMATISM, vol 63, issue 10, pp S727-S728

Ph.D. Theses

Daniel Söderberg
  The Contribution of Innate Immunity to the Pathogenesis of ANCA-associated Vasculitis

  Fulltext PDF

* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.


Responsible for this page: Peter Berkesand
Last updated: 2010-08-30